Multitude Therapeutics Inc.
Clinical trials sponsored by Multitude Therapeutics Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cancer drug AMT-676 enters first human tests Results expected May 2027 (estimated)
- New drug duo takes on advanced lung cancer Results expected May 2027 (estimated)